Global /China /Healthcare /Drug Manufacturers - General /002900

Harbin Medisan Pharmaceutical Co., Ltd.

002900

• SHE: 002900 • Delayed

11.56CNY 0.1%

1.71 USD

As of 14 June 2026, Harbin Medisan Pharmaceutical Co., Ltd. has a market cap of $527.62M USD, ranking #14773 globally and #4594 in China. It ranks #1314 in the Healthcare sector, and #485 in the Drug Manufacturers - General industry.

Global Rank

14773

Country Rank

4594

Sector Rank

1314

Industry Rank

485

Key Stats

Market Cap

$527.62MUSD

3.58B CNY

Enterprise Value

$608.46MUSD

4.12B CNY

Revenue (TTM)

$120.02MUSD

813.23M CNY

EBITDA (TTM)

-$17.1MUSD

-115.71M CNY

Net Income (TTM)

-$46.91MUSD

-317.84M CNY

EBITDA Margin

-14%

Profit Margin

-39%

PS Ratio

4.4

PB Ratio

2.0

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jian Fei Qin open_in_new

Employees

2,522

Founded

1996

Website

medisan.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.1%	8.4%	-0.9%	-2.6%	-16%	-7.2%	5.9%	-14%	-36%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002900 哈尔滨三联药业股份有限公司 Class A ISIN: CNE1000032V9 Shares Out.: Shares Outstanding: 316.355M¹ Shares Float: 239.186M² TV: TradingView: SZSE: 002900 SA: Stock Analysis: SHE: 002900 YF: Yahoo Finance: 002900.SZ GF: Google Finance: SHE: 002900 BA: Barron's: 002900 MS: Morningstar: XSHE: 002900	11.56 CNY	TV: TradingView: SZSE: 002900 SA: Stock Analysis: SHE: 002900 YF: Yahoo Finance: 002900.SZ GF: Google Finance: SHE: 002900 BA: Barron's: 002900 MS: Morningstar: XSHE: 002900

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Harbin Medisan Pharmaceutical Co., Ltd.

Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale chemical pharmaceutical preparations in China. The company offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, and body fluid balance infusion; and other products, including oxaliplatin for injection, calcium folinate for injection, hydroxylcamptothecine injection, tropisetron hydrochloride for injection, tropisetron hydrochloride and glucose injection, gabexate mesylate for injection, bismuth potassium citrate granules, pantoprazole sodium for injection, ambroxol hydrochloride and glucose injection, asarone for injection, paracetamol and tramadol hydrochloride tablets, rifamycin sodium for injection, lornoxicam for injection, vecuronium bromide for injection, and vitamin c for injection. It also provides medical devices and cosmetics. Harbin Medisan Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Harbin, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 10K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 9K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 5K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 3K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 3K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 3K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 144K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 104K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 68K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 61K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 55K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 52K%	20.5	Switzerland

chevron_leftBack